Literature DB >> 8499907

The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE.

M C Hirst1, A Barnicoat, G Flynn, Q Wang, M Daker, V J Buckle, K E Davies, M Bobrow.   

Abstract

FRAXA is unique amongst fragile sites in that it is intimately involved with a specific clinical phenotype, the fragile X syndrome. Whilst the majority of fragile X individuals have been found to have a characteristic mutation in the FMR1 gene, a small proportion of individuals exhibiting fragility have no such mutation. Investigation of the site of chromosome fragility in these FMR1 mutation negative, fragile X site positive individuals, has identified a second site of fragility, FRAXE. However, the presence of FRAXE has not explained all such cases. Here we describe a fragile X site positive, FMR1 mutation negative family, in which chromosome fragility is not due to the FRAXA or FRAXE but is due to a third site designated FRAXF. Using fluorescent in situ hybridisation (FISH) this site is shown to lie over 1Mb distal to FRAXA. The identification of a third fragile site in this small region of the X chromosome provides an opportunity to extend our studies of the molecular nature of chromosome fragility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499907     DOI: 10.1093/hmg/2.2.197

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom.

Authors:  S J Knight; R J Ritchie; L Chakrabarti; G Cross; G R Taylor; R F Mueller; J Hurst; J Paterson; J R Yates; D J Dow; K E Davies
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

2.  Fragile X syndrome is less common than previously estimated.

Authors:  J E Morton; S Bundey; T P Webb; F MacDonald; P M Rindl; S Bullock
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

3.  The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.

Authors:  P Steinbach; D Gläser; W Vogel; M Wolf; S Schwemmle
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Clinical, cytogenetic, and molecular analysis of three families with FRAXE.

Authors:  A J Barnicoat; Q Wang; J Turk; E Green; C G Mathew; G Flynn; V Buckle; M Hirst; K Davies; M Bobrow
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

Review 5.  Huntington disease: advances in molecular and cell biology.

Authors:  A L Jones; J D Wood; P S Harper
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro.

Authors:  K Usdin; K J Woodford
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

7.  Fragile X syndrome.

Authors:  J Turk
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

8.  FRAXF in a patient with chromosome 8 duplication.

Authors:  A M Vianna-Morgante; R C Mingroni-Netto; A C Barbosa; P A Otto; C Rosenberg
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

9.  A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease-Relevant Epivariations and CGG Expansions.

Authors:  Paras Garg; Bharati Jadhav; Oscar L Rodriguez; Nihir Patel; Alejandro Martin-Trujillo; Miten Jain; Sofie Metsu; Hugh Olsen; Benedict Paten; Beate Ritz; R Frank Kooy; Jozef Gecz; Andrew J Sharp
Journal:  Am J Hum Genet       Date:  2020-09-15       Impact factor: 11.025

10.  Autism spectrum disorder: FRAXE mutation, a rare etiology.

Authors:  F Correia; C Café; J Almeida; S Mouga; G Oliveira
Journal:  J Autism Dev Disord       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.